CSL, AU000000CSL8

CSL stock: Macquarie keeps target at AUD 174.00 for CSL stock

Published on 10/23/2026 at 15:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revenue reached AUD 7.31 billion for the quarter ending June 30, 2026. CSL stock costs EUR 121.60 on October 23, 2026 at 3:04 p.m. CEST.

Macquarie keeps a Hold view

  • Macquarie maintained its Hold rating and set an AUD 174.00 target on October 22, 2026.
  • CSL's quarterly revenue reached AUD 7.31 billion for the period ending June 30, 2026.
  • CSL stock costs EUR 121.60 at Lang & Schwarz on October 23, 2026 at 3:04 p.m. CEST.
  • CSL's annual general meeting is scheduled for October 27, 2026.
CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (AU000000CSL8) is carrying a fresh analyst valuation of AUD 174.00 after TipRanks reported on October 22, 2026 that Macquarie maintained its Hold rating. The stock was trading at EUR 121.60 at Lang & Schwarz on October 23, 2026 at 3:04 p.m. CEST.

Macquarie sets a lower target

Macquarie's AUD 174.00 target sits below CSL's latest Australian quotation of AUD 196.70 on October 23, 2026 at 4:10 p.m. AEDT. The price is 13.05 percent above that target, a numerical gap that leaves the broker's Hold stance as the clearest current valuation signal.

Revenue reached AUD 7.31 billion

For the quarter ending June 30, 2026, CSL reported revenue of AUD 7.31 billion and a GAAP net loss of AUD 2.94 billion, according to TipRanks. Revenue was AUD 7.26 billion in the comparable quarter, while the prior-year period produced a GAAP net profit of AUD 1.03 billion. The figures put the latest quarter's top-line growth at 0.69 percent, alongside a sharp earnings reversal.

What comes before the annual meeting?

CSL's 2026 annual general meeting is scheduled for October 27, 2026, in Melbourne and online, according to the company's CSL investor information. The meeting is the next dated corporate event for shareholders.

CSL remains above the target

For investors, the key tension is the contrast between the AUD 174.00 analyst target and the AUD 196.70 Australian quotation. CSL's latest quarter also combines AUD 7.31 billion in revenue with a AUD 2.94 billion GAAP net loss, making the earnings mix as important as the headline sales figure. The stock was trading at EUR 121.60 at Lang & Schwarz on October 23, 2026 at 3:04 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of CSL stock.

CSL stock facts

  • Company: CSL Limited
  • ISIN: AU000000CSL8
  • Ticker: CSL
  • Primary exchange: ASX
  • Price Lang & Schwarz (as of October 23, 2026, 3:04 p.m. CEST): EUR 121.60
  • Market capitalization: AUD 94.4 billion (as of October 23, 2026)
  • Sector / Industry: Healthcare / Biotechnology
  • Next earnings date: October 27, 2026

Market context: Market report S&P/ASX 200.

More news and analyses on CSL stock

Disclaimer...
en | AU000000CSL8 | CSL | boerse | 70399141 | bgmi